Fundraising Fox노보렉스
1 known investors
Find your way into 노보렉스
Sign up to see every warm intro you have to 노보렉스
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 노보렉스 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novorex is a drug discovery company that combines AI, fragment-based drug discovery (FBDD), and biophysical validation (SPR, NMR, X-ray crystallography, and wet-lab assays) to develop novel small-molecule therapeutics. It operates in-house CNS and inflammation pipelines with R&D labs in Pangyo, Central, and Jeongeup.
Investors · 1
Related companies · 4
Renovo RxRenovoRx develops targeted oncology therapies and commercializes the RenovoCath, an FDA-cleared drug-delivery device for intra-arterial chemotherapy administration in cancer treatment. The company is conducting Phase III clinical trials of its proprietary TAMP therapy platform for treating locally advanced pancreatic cancer with improved safety and efficacy compared to systemic chemotherapy.
Nurix TherapeuticsNurix Therapeutics develops protein degrader-based medicines using proprietary DEL-AI discovery technology to address cancer and autoimmune diseases. The company applies targeted protein degradation to overcome limitations of conventional therapeutic approaches.
Regenx BiosciencesREGENXBIO is a gene therapy company developing treatments for rare and retinal diseases using its NAV Technology Platform of viral vectors, which it also licenses to other pharmaceutical and biotech companies. It operates a late-stage clinical pipeline and manufactures its investigational gene therapies at its facility in Rockville, MD.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies working in the same space as 노보렉스.
Frequently asked questions
- What does 노보렉스 do?
- Novorex is a drug discovery company that combines AI, fragment-based drug discovery (FBDD), and biophysical validation (SPR, NMR, X-ray crystallography, and wet-lab assays) to develop novel small-molecule therapeutics. It operates in-house CNS and inflammation pipelines with R&D labs in Pangyo, Central, and Jeongeup.
- Who are 노보렉스's investors?
- 노보렉스's investors include Solidus Investment.